Tag: respiratory drugs
ASP: Budesonide takes a dive
April 6, 2016HME News Staff
BALTIMORE - Second quarter payments for respiratory drugs are up in most cases, with the exception of Budesonide (J7626), which decreased sharply, down nearly 73 cents per dose. Perforomist (J7606) saw the biggest increase, up 41 cents to $9.82 per dose, according to the latest average sales price (ASP) figures. Brovana (J7605) increased 24 cents to $8.50 per dose. Albuterol (J7613) and ipratropium (J7644) stayed fairly flat, at 12.5 cents per dose and 10.5 cents per dose, respectively.
Mickey Letson's back in business.
September 30, 2009Mike Moran
A little over two years after he sold Letco, a high profile distributor of respiratory drugs and related products, to the Harvard Drug Group, he's running a technology company, Dream Software, and developing products intended to make HME providers more efficient.
"Everything we are doing here is built around one thing: We believe for you to survive long term, you have to generate more revenue and service more patients with less people," Letson said. "If you can't do that, you will never survive...
